<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Surg</journal-id><journal-id journal-id-type="iso-abbrev">Int J Surg</journal-id><journal-id journal-id-type="pmc-domain-id">2035</journal-id><journal-id journal-id-type="pmc-domain">lwwopen</journal-id><journal-id journal-id-type="publisher-id">JS9</journal-id><journal-title-group><journal-title>International Journal of Surgery (London, England)</journal-title></journal-title-group><issn pub-type="ppub">1743-9191</issn><issn pub-type="epub">1743-9159</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Lippincott Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430868</article-id><article-id pub-id-type="pmcid-ver">PMC12430868.1</article-id><article-id pub-id-type="pmcaid">12430868</article-id><article-id pub-id-type="pmcaiid">12430868</article-id><article-id pub-id-type="pmid">40552893</article-id><article-id pub-id-type="doi">10.1097/JS9.0000000000002756</article-id><article-id pub-id-type="publisher-id">IJS-D-25-02319</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Correspondence</subject></subj-group></article-categories><title-group><article-title>Letter to the Editor: &#8220;an updated systematic review, meta-analysis, and trial sequential analysis of the efficacy and safety of en bloc transurethral resection vs. conventional transurethral resection for nonmuscle-invasive bladder tumor&#8221;</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="C">Chao</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="Y">Yanfei</given-names></name><degrees>MD</degrees><email>13296396007@139.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Z">Zongyao</given-names></name><degrees>MD</degrees><email>2597372377@qq.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wang</surname><given-names initials="X">Xiaoxi</given-names></name><degrees>MD</degrees><email>wxxlab@163.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>a</label>The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China</aff><aff id="aff2"><label>b</label>Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China</aff></contrib-group><author-notes><corresp id="COR0001"><label>*</label>Corresponding author. Address: The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China. Tel.: +86 18098877262. E-mail: <email>wxxlab@163.com</email> (X. Wang).</corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>17</day><month>6</month><year>2025</year></pub-date><volume>111</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496813</issue-id><fpage>6571</fpage><lpage>6572</lpage><history><date date-type="received"><day>13</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>02</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyndlicense">https://creativecommons.org/licenses/by-nd/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">Creative Commons Attribution-NoDerivatives License 4.0</ext-link>, which allows for redistribution, commercial and noncommercial, as long as it is passed along unchanged and in whole, with credit to the author.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="js9-111-6571.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="js9-111-6571.pdf"/><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>
<italic toggle="yes">Dear Editor,</italic>
</p><p>We read with great interest the article by Zeng <italic toggle="yes">et al</italic><sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup>, which through a rigorous randomized controlled trial design demonstrated that preoperative parecoxib significantly reduces the incidence of postoperative delirium (POD) in patients with hyperlipidemia. This effect is attributed to dual mechanisms: inhibition of COX-2-mediated inflammatory responses and postoperative pain control, providing important evidence for perioperative neurocognitive protection. Here, we share some thoughts and suggestions to further enrich the discussion.</p><p>In this study, ERBT significantly reduced the tumor recurrence rate at 3&#8211;6&#160;months and the same-site recurrence rate at 1 year. This phenomenon may be explored in deeper detail from the multi-step regulatory mechanisms of tumor cell dissemination. Notably, gastrointestinal surgery induces a unique &#8220;gut-brain axis&#8221; inflammatory response: surgical trauma may compromise intestinal barrier function, leading to endotoxin translocation and systemic release of enteric cytokines (e.g., IL-6, TNF-&#945;)<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup>. These cytokines can activate central microglia via vagal pathways or a damaged blood-brain barrier, triggering neuroinflammatory cascades. Patients with hyperlipidemia often exhibit gut microbiota dysbiosis and intestinal mucosal lipid metabolism abnormalities<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup>, which may exacerbate intestinal barrier dysfunction and promote enteric cytokine translocation into the brain, thereby increasing the risk of neuroinflammation-mediated POD. Future research incorporating simultaneous detection of intestinal permeability markers (e.g., diamine oxidase, lipopolysaccharide) and central inflammatory biomarkers (e.g., cerebrospinal fluid PGE2) could clarify parecoxib&#8217;s role in regulating gut&#8211;brain axis inflammation.</p><p>The subgroup analysis revealed that parecoxib was more effective in preventing POD among patients with &#8220;mild hyperlipidemia&#8221; than those with &#8220;marked hyperlipidemia&#8221;. This suggests that the severity of hyperlipidemia may influence the neuroprotective efficacy of COX-2 inhibitors. Pathophysiologically, excessive cholesterol in marked hyperlipidemia might promote &#946;-amyloid deposition and degrade blood-brain barrier tight junction proteins (e.g., claudin-5), increasing barrier permeability while reducing drug penetration efficiency<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup>. Such structural and functional abnormalities in the neurovascular unit may impair the delivery of parecoxib to the central nervous system, weakening its inhibition of central inflammation. Combining imaging techniques (e.g., MRI to assess blood-brain barrier integrity) with cerebrospinal fluid drug concentration measurements could further validate this hypothesis. Meanwhile, in the future, network meta-analysis can be used to compare the long-term efficacy of different energy platforms (holmium laser, 2-&#956;m laser, bipolar resection), while incorporating health technology assessment metrics such as operation time and learning curve, so as to establish a technology selection model based on tumor characteristics (such as size and location).</p><p>This study provides crucial clinical evidence for perioperative neuroprotection in hyperlipidemic patients. We appreciate the authors&#8217; efforts and commend their contributions to the field. We hope that future research may expand sample sizes, extend follow-up periods, and integrate molecular and imaging techniques to deepen our understanding of the dose-effect relationship and long-term outcomes. These steps would strengthen the evidence base for precision interventions and improve long-term prognoses for surgical patients. We sincerely thank you for authors support.</p></body><back><fn-group><fn fn-type="other"><p>Chao Wu, Zongyao Liu and Yanfei Yang are contributed equally as co-first authors.</p></fn><fn fn-type="equal"><p>Published online 17 June 2025</p></fn></fn-group><sec><title>Ethical approval</title><p>None.</p></sec><sec><title>Consent</title><p>None.</p></sec><sec><title>Sources of funding</title><p>There is no any funding.</p></sec><sec><title>Author contributions</title><p>Z.L., Y.Y., and C.W. were responsible for the manuscript. X.W. was responsible for writing and reviewing manuscripts.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest disclosure</title><p>The authors have no conflicts to report.</p></sec><sec><title>Guarantor</title><p>Xiaoxi Wang.</p></sec><sec><title>Research registration unique identifying number (UIN)</title><p>None.</p></sec><sec><title>Provenance and peer review</title><p>Not commissioned, externally peer-reviewed.</p></sec><sec sec-type="data-availability"><title>Data availability statement</title><p>None.</p></sec><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daojun</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yuling</surname><given-names>T</given-names></name><name name-style="western"><surname>Yingzhe</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Effect of parecoxib on postoperative delirium in patients with hyperlipidemia: a randomized, double-blind, single-center, superiority trial</article-title>. <source>Int J Surg</source><year>2025</year>;<volume>111</volume>:<fpage>2903</fpage>&#8211;<lpage>13</lpage>.<pub-id pub-id-type="pmid">39903567</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/JS9.0000000000002286</pub-id><pub-id pub-id-type="pmcid">PMC12175806</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Huang</surname><given-names>F</given-names></name><name name-style="western"><surname>Fan</surname><given-names>W</given-names></name></person-group>. <article-title>Systemic inflammation, neuroinflammation and perioperative neurocognitive disorders</article-title>. <source>Inflamm Res</source><year>2023</year>;<volume>72</volume>:<fpage>1895</fpage>&#8211;<lpage>907</lpage>.<pub-id pub-id-type="pmid">37688642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00011-023-01792-2</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hansen</surname><given-names>SB</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name></person-group>. <article-title>The shared role of cholesterol in neuronal and peripheral inflammation</article-title>. <source>Pharmacol Ther</source><year>2023</year>;<volume>249</volume>:<fpage>108486</fpage>.<pub-id pub-id-type="pmid">37390970</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pharmthera.2023.108486</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Dios C</surname></name><name name-style="western"><surname>Abadin</surname><given-names>X</given-names></name><name name-style="western"><surname>Roca-Agujetas</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis</article-title>. <source>Transl Neurodegener</source><year>2023</year>;<volume>12</volume>:<fpage>10</fpage>.<pub-id pub-id-type="pmid">36895045</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40035-023-00343-3</pub-id><pub-id pub-id-type="pmcid">PMC9996936</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>